Skip to main content
OLIPASS CORPORATION logo

OLIPASS CORPORATION — Investor Relations & Filings

Ticker · 244460 ISIN · KR7244460002 KO Professional, scientific and technical activities
Open in API
Filings indexed 505 across all filing types
Latest filing 2026-03-31 Declaration of Voting R…
Country KR South Korea
Listing KO 244460

About OLIPASS CORPORATION

https://www.olipass.com/front/eng/index…

OLIPASS CORPORATION is a research and development company focused on creating RNA therapeutics. The company's core activities are centered on its proprietary OliPass Peptide Nucleic Acid (OPNA) platform. OPNA is a novel technology derived from Peptide Nucleic Acid (PNA) by introducing a cationic lipid moiety onto the nucleobase. This structural modification is designed to markedly improve cell permeability, a key challenge in nucleic acid-based drug delivery. The platform is optimized to induce exon skipping by specifically binding to target pre-mRNA inside the cell nucleus, enabling the discovery and development of new therapeutic candidates.

Recent filings

Filing Released Lang Actions
[기재정정]정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is an amendment (“정정신고(보고)”) of the Annual General Meeting results, listing votes on financial statements, director appointments, and compensation limits. It is the official declaration of voting outcomes at the AGM, matching “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2026-03-31 Korean
[기재정정]사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 88% confidence The document is a regulatory filing in Korean titled “사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고,” reporting the appointment (and correction) of an outside director. It details board composition changes, appointment dates, and director biographies. This fits the Board/Management Information category.
2026-03-31 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 95% confidence The document is a formal notification to the Financial Services Commission/KRX regarding the appointment and dismissal of an outside director (‘사외이사’). It details changes in board composition, including names, dates of appointment, and terms. This clearly fits the Board/Management Information category, which covers announcements of changes in the company’s board of directors or senior management. It is not a financial report, earnings release, or proxy statement but specifically a board change notice.
2026-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is the official ‘정기주주총회 결과’ (Annual General Meeting results) detailing each resolution item, vote counts, approval rates, and the election of directors. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers shareholder vote outcomes at general meetings.
2026-03-30 Korean
[기재정정]투자판단관련주요경영사항 (신약 공동연구개발 연구개발비 수령)
Regulatory Filings Classification · 72% confidence The document is a Korean KRX disclosure titled “투자판단 관련 주요경영사항” (Material Matters Related to Investment Decisions) with details on contract extension and R&D fee receipt from Vanda Pharmaceuticals. It is neither a full financial report (10-K/IR), earnings release (ER), nor any of the other specific categories (board changes, financing, dividends, share transactions, etc.). It is a standalone regulatory announcement of a material event. Therefore it falls under the fallback category “Regulatory Filings” (RNS).
2026-03-26 Korean
[기재정정]투자판단관련주요경영사항 (신약 공동연구개발 연구개발비 수령)
Regulatory Filings Classification · 75% confidence The document is a Korean stock exchange regulatory disclosure titled “투자판단 관련 주요경영사항,” describing receipt of R&D fees under a joint research agreement and a correction to a prior filing. It is a standalone material event announcement, not a financial report, earnings release, or other defined category. As it does not fit specialized types (e.g., earnings, M&A, dividends, etc.), it falls under the general “Regulatory Filings” fallback category.
2026-03-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.